This is a limited company view. Sign up for a Free Trial to see everything.

TaiMed Biologics offers Ibalizumab, a monoclonal antibody and a member of HIV viral-entry inhibitor therapy.

Overview

Location

Taipei City

Founded

Employees

0

Stage

Public

Total funding

$22M

Last funding

8 years ago

Acquisitions

0

Growth score

0

Mindshare score

0

Scoring

Deals

Employee Growth

Use TaiMed Biologics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use TaiMed Biologics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial